Department of Gastroenterology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-0001, Japan.
Department of Pathology, Toranomon Hospital, Tokyo, Japan.
Clin J Gastroenterol. 2020 Aug;13(4):626-631. doi: 10.1007/s12328-019-01090-7. Epub 2020 Jan 8.
We report a case of simultaneous macroamylasemia and macrolipasemia complicated with mucosa-associated lymphoid tissue (MALT) lymphoma. A 78-year-old man presented with hyperamylasemia and hyperlipasemia for 2 years and was misdiagnosed with chronic pancreatitis at another hospital. However, his other pancreatic enzymes were normal, his amylase-creatinine clearance ratio was low, and no definite findings of pancreatic disease were evident. Immunological analyses revealed that both amylase and lipase were bound to immunoglobulin (Ig) A-κ, and that serum IgA was high (827.1 mg/dL). He was diagnosed with simultaneous macroamylasemia and macrolipasemia. Since these diseases are associated with malignancy, an additional investigation was performed which revealed the complication of MALT lymphoma, and polymerase chain reaction analysis showed monoclonal immunoglobulin light chain gene rearrangement (κ >> λ). In this case, macroamylasemia and macrolipasemia may have developed due to the formation of macroenzymes resulting from excess IgA-κ secreted by the MALT lymphoma. Simultaneous macroamylasemia and macrolipasemia are very rare and difficult to diagnose and can lead to diagnostic and therapeutic errors. When encountering atypical clinical features associated with hyperamylasemia and hyperlipasemia, the possibility of macroenzymes and underlying diseases such as lymphoproliferative disorders should be considered.
我们报告一例同时伴有巨淀粉酶血症和巨脂酶血症的黏膜相关淋巴组织(MALT)淋巴瘤病例。一名 78 岁男性因高淀粉酶血症和高脂血症就诊 2 年,曾在另一医院误诊为慢性胰腺炎。然而,他的其他胰腺酶正常,淀粉酶肌酐清除率比值低,胰腺疾病无明确发现。免疫分析显示,淀粉酶和脂肪酶均与免疫球蛋白(Ig)A-κ 结合,血清 IgA 升高(827.1mg/dL)。他被诊断为同时伴有巨淀粉酶血症和巨脂酶血症。由于这些疾病与恶性肿瘤有关,因此进行了进一步检查,发现并发 MALT 淋巴瘤,并通过聚合酶链反应分析显示单克隆免疫球蛋白轻链基因重排(κ>>λ)。在这种情况下,巨淀粉酶血症和巨脂酶血症可能是由于 MALT 淋巴瘤分泌过多的 IgA-κ 形成巨酶所致。同时伴有巨淀粉酶血症和巨脂酶血症非常罕见且难以诊断,可能导致诊断和治疗错误。当遇到与高淀粉酶血症和高脂血症相关的非典型临床特征时,应考虑巨酶和潜在疾病的可能性,如淋巴增生性疾病。